What is Celltrio?
Celltrio, Inc. specializes in developing and delivering high-value automation solutions tailored for biobanking and cell line development processes. The increasing demand in the cell culture and harvesting automation market is largely propelled by the imperative to accelerate the time-to-market for new pharmaceuticals. Celltrio's automation technology directly addresses this need by significantly reducing experimental execution times and associated costs, thereby allowing scientific researchers to concentrate on core research rather than manual manipulation of experimental materials.
How much funding has Celltrio raised?
Celltrio has raised a total of $30M across 2 funding rounds:
Other Financing Round
$15M
Private Equity
$15M
Other Financing Round (2025): $15M with participation from AEG Premier Partner
Private Equity (2025): $15M, investors not publicly disclosed
Key Investors in Celltrio
AEG Premier Partner
AEG Premier Partner is a program focused on supporting independent kitchen studio businesses through superior service, leading brands, and innovative technology. Their approach emphasizes anticipating customer needs to achieve exceptional results, positioning them as a forward-thinking entity in their sector.
What's next for Celltrio?
With a substantial enterprise-level funding round, Celltrio is strategically positioned for accelerated growth and innovation. The recent major strategic investment signals strong confidence from backers in the company's mission to revolutionize biobanking and cell line development through automation. This capital infusion is expected to fuel further research and development, enhance production capabilities, and expand market reach, solidifying Celltrio's leadership in a sector critical to drug discovery and development.
See full Celltrio company page
